The Prevalence of Thiamin Deficiency in Ambulatory Patients With Heart Failure
1 other identifier
observational
110
1 country
1
Brief Summary
Patients with heart failure are at an increased risk for thiamin deficiency (TD), for many reasons such as malnutrition and the use of diuretic drugs. Thiamin is a B vitamin that plays an important role in the production of energy in body. Therefore, low levels of thiamin may limit the amount of energy available for the heart to pump blood. Recent thiamin supplementation trials have demonstrated significant improvements in heart function. However, while clinically important, the results of these studies are limited by their small sample sizes, indirect measurement of thiamin status and reliance on hospitalized patients. Therefore, the investigators' goal is to determine the prevalence of thiamin deficiency in ambulatory patients with heart failure by direct measurement of thiamin in red blood cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 4, 2009
CompletedFirst Posted
Study publicly available on registry
August 6, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 24, 2012
December 1, 2012
3.5 years
August 4, 2009
December 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Thiamin deficiency as determined by Erythrocyte thiamin pyrophosphate (TPP) measured using a direct HPLC technique
baseline
Secondary Outcomes (3)
Eligible patients will be randomized to one of three commercially available doses of oral thiamin hydrochloride; 50 mg QD, 50 mg BID and 100 mg BID. They will take the supplements for 2 weeks.
baseline to after two weeks of supplementation
Plasma samples will be analyzed for the plasma levels of NE, BNP, F2-isoprostanes
baseline and after supplementation
Urinary excretion of thiamin following the 2 week supplementation period.
by the end of two-week supplementation period
Eligibility Criteria
Cardiology Clinic (St Michael's Hospital)
You may qualify if:
- Patients with the primary diagnosis of ischemic, dilated, idiopathic or valvular HF characterized by an ejection fraction of \< 45% (echocardiography or radionuclide scan)
- Patients with NYHA class I-IV symptoms
You may not qualify if:
- Patients who are unable or unwilling to provide informed consent
- Patients with any concurrent condition which would result in TD, namely, gastrointestinal disorders (Crohn's disease, ulcerative colitis), liver disease, prolonged diarrhoeal disease, dialysis, prolonged fever, infection or renal failure
- Patients who are rapidly deteriorating, who are not on a stable medication regimen (≥ 2 months) or have been hospitalized for acute decompensated HF in the last 2 months
- Patients who are on experimental medications
- Patients who consume excessive alcohol (\> 3 drinks per day), have a documented history of alcoholism or have documented alcoholic cardiomyopathy
- Patients who are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Michael's Hospital
Toronto, Ontario, Canada
Biospecimen
Blood test
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Keith, PhD, RD
Unity Health Toronto
- PRINCIPAL INVESTIGATOR
Andrew Yan, MD
Cardiologist, St. Michael's Hospital
- PRINCIPAL INVESTIGATOR
Abdul Al-Hesayen, MD
Cardiologist, St. Michael's Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinator of Nutrition and Dietetic Education/Research
Study Record Dates
First Submitted
August 4, 2009
First Posted
August 6, 2009
Study Start
May 1, 2009
Primary Completion
November 1, 2012
Study Completion
December 1, 2012
Last Updated
December 24, 2012
Record last verified: 2012-12